These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27375783)

  • 1. Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.
    Xing H; Hwang K; Lu Y
    Theranostics; 2016; 6(9):1336-52. PubMed ID: 27375783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
    Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
    Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Functional Liposome: A Powerful Theranostic Nano-Platform Enhancing Photodynamic Therapy.
    Cheng X; Gao J; Ding Y; Lu Y; Wei Q; Cui D; Fan J; Li X; Zhu E; Lu Y; Wu Q; Li L; Huang W
    Adv Sci (Weinh); 2021 Aug; 8(16):e2100876. PubMed ID: 34085415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application.
    Qu W; Zuo W; Li N; Hou Y; Song Z; Gou G; Yang J
    J Drug Target; 2017 Sep; 25(8):661-672. PubMed ID: 28438041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 8. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.
    Sonali ; Singh RP; Singh N; Sharma G; Vijayakumar MR; Koch B; Singh S; Singh U; Dash D; Pandey BL; Muthu MS
    Drug Deliv; 2016 May; 23(4):1261-71. PubMed ID: 26961144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
    Huang D; He B; Mi P
    Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer.
    Jha A; Viswanadh MK; Burande AS; Mehata AK; Poddar S; Yadav K; Mahto SK; Parmar AS; Muthu MS
    Int J Biol Macromol; 2020 May; 150():413-425. PubMed ID: 32057849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.
    Beztsinna N; Tsvetkova Y; Jose J; Rhourri-Frih B; Al Rawashdeh W; Lammers T; Kiessling F; Bestel I
    Int J Nanomedicine; 2017; 12():3813-3825. PubMed ID: 28572726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Nanoparticles in Cancer Theranostics.
    Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
    Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer theranostic applications of lipid-based nanoparticles.
    Tang WL; Tang WH; Li SD
    Drug Discov Today; 2018 May; 23(5):1159-1166. PubMed ID: 29660478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
    Wei X; Song M; Li W; Huang J; Yang G; Wang Y
    Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiopharmaceutical enhancement by drug delivery systems: A review.
    Kleynhans J; Grobler AF; Ebenhan T; Sathekge MM; Zeevaart JR
    J Control Release; 2018 Oct; 287():177-193. PubMed ID: 30086338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y; Han X; Jing X; Chen Y
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SWCNTs as novel theranostic nanocarriers for cancer diagnosis and therapy: towards safe translation to the clinics.
    Al Faraj A
    Nanomedicine (Lond); 2016 Jun; 11(11):1431-45. PubMed ID: 27172091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.